Wordt geladen...
Destroyed lung due to sustained inflammation after chemoradiotherapy followed by durvalumab
A 68‐year‐old male patient with squamous cell carcinoma (cT4N2M0) of the left upper lobe received chemoradiotherapy followed by durvalumab, an immune checkpoint inhibitor. The tumour responded well to the therapy, but an infiltrative shadow appeared in the left upper lobe, which was outside the radi...
Bewaard in:
| Gepubliceerd in: | Respirol Case Rep |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley & Sons, Ltd
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7211830/ https://ncbi.nlm.nih.gov/pubmed/32399215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.580 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|